GT Biopharma Inc (GTBP) Income Statement

Total revenue

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

-100.00%0.00

-20.00%20.00K

--7.00K

-19.51%33.00K

-98.36%3.00K

-55.36%25.00K

-100.00%0.00

-81.28%41.00K

52.50%183.00K

5500.00%56.00K

8700.00%88.00K

--219.00K

--120.00K

--1.00K

Revenue

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

-100.00%0.00

-20.00%20.00K

--7.00K

-19.51%33.00K

-98.36%3.00K

-55.36%25.00K

-100.00%0.00

-81.28%41.00K

52.50%183.00K

5500.00%56.00K

8700.00%88.00K

--219.00K

--120.00K

--1.00K

Cost of revenue

----

--0.00

----

--0.00

----

--0.00

----

--0.00

-100.00%0.00

--0.00

59.09%35.00K

-95.93%5.00K

41.67%17.00K

-100.00%0.00

-63.93%22.00K

284.38%123.00K

--12.00K

6800.00%69.00K

--61.00K

--32.00K

--0.00

--1.00K

Operating expenses

-37.50%1.93M

18.78%3.76M

15.44%3.60M

7.87%3.91M

-15.66%3.09M

-45.17%3.17M

-55.55%3.12M

20.14%3.62M

-32.65%3.67M

-68.21%5.78M

17.95%7.02M

-31.20%3.01M

-81.24%5.44M

729.67%18.18M

206.12%5.95M

181.19%4.38M

2610.47%29.00M

153.00%2.19M

-54.30%1.94M

-31.64%1.56M

-73.62%1.07M

-71.98%866.00K

-30.75%4.26M

-55.81%2.28M

-43.35%4.06M

-47.53%3.09M

-95.16%6.15M

301.32%5.16M

365.54%7.16M

616.67%5.89M

4914.07%126.86M

-39.42%1.28M

-60.57%1.54M

-71.73%822.00K

-8.89%2.53M

46.18%2.12M

114.58%3.90M

73.61%2.91M

403.08%2.78M

1024.81%1.45M

1700.00%1.82M

513.55%1.68M

70.90%552.00K

-0.77%129.00K

-76.78%101.00K

-71.50%273.00K

-78.03%323.00K

-87.39%130.00K

9.57%435.00K

--958.00K

--1.47M

--1.03M

--397.00K

R&D expenses

41.44%1.10M

42.23%1.93M

-4.18%1.31M

-14.84%1.78M

-52.91%777.00K

-52.25%1.36M

-50.27%1.36M

83.93%2.10M

-20.94%1.65M

-54.92%2.84M

172.12%2.74M

78.25%1.14M

27.26%2.09M

2605.58%6.30M

1300.00%1.01M

5225.00%639.00K

406.17%1.64M

2812.50%233.00K

-112.52%-84.00K

-92.21%12.00K

-61.15%324.00K

-99.35%8.00K

-39.60%671.00K

-95.26%154.00K

-75.99%834.00K

684.71%1.23M

111.22%1.11M

1248.96%3.25M

2311.81%3.47M

-37.20%157.00K

110.40%526.00K

-3.60%241.00K

-36.00%144.00K

-52.38%250.00K

11.11%250.00K

--250.00K

-10.00%225.00K

--525.00K

--225.00K

--0.00

--250.00K

--0.00

Depreciation, depletion, and amortization

--0.00

----

--0.00

----

-100.00%0.00

----

-100.00%0.00

800.00%9.00K

0.00%1.00K

--2.00K

200.00%3.00K

--1.00K

0.00%1.00K

--0.00

0.00%1.00K

--0.00

--1.00K

-100.00%0.00

--1.00K

--0.00

-100.00%0.00

--1.00K

--0.00

--1.00K

----

--0.00

----

Operating profit

37.50%-1.93M

-18.78%-3.76M

-15.44%-3.60M

-7.87%-3.91M

15.66%-3.09M

45.17%-3.17M

55.55%-3.12M

-20.14%-3.62M

32.65%-3.67M

68.21%-5.78M

-17.95%-7.02M

31.20%-3.01M

81.24%-5.44M

-729.67%-18.18M

-206.12%-5.95M

-181.19%-4.38M

-2610.47%-29.00M

-153.00%-2.19M

54.30%-1.94M

31.64%-1.56M

73.62%-1.07M

71.98%-866.00K

30.75%-4.26M

55.81%-2.28M

43.35%-4.06M

47.53%-3.09M

95.16%-6.15M

-301.32%-5.16M

-365.54%-7.16M

-616.67%-5.89M

-4914.07%-126.86M

39.42%-1.28M

60.57%-1.54M

71.73%-822.00K

8.89%-2.53M

-48.22%-2.12M

-115.41%-3.90M

-77.10%-2.91M

-405.83%-2.78M

-1275.96%-1.43M

-1693.07%-1.81M

-607.76%-1.64M

-292.14%-549.00K

-40.54%-104.00K

70.89%-101.00K

68.61%-232.00K

89.63%-140.00K

92.82%-74.00K

12.37%-347.00K

---739.00K

---1.35M

---1.03M

---396.00K

Net non-operating interest income (expenses)

Non-operating interest income

-77.46%32.00K

-67.22%59.00K

-55.56%96.00K

-52.27%105.00K

-13.41%142.00K

27.66%180.00K

101.87%216.00K

511.11%220.00K

1950.00%164.00K

2250.00%141.00K

234.38%107.00K

--36.00K

--8.00K

--6.00K

--32.00K

----

Non-operating interest expense

----

--0.00

-100.00%0.00

--0.00

--1.00K

--212.00K

-63.64%8.00K

--0.00

-100.00%0.00

--22.00K

-100.00%0.00

9.09%696.00K

----

66.25%931.00K

872.44%4.66M

40.53%638.00K

-44.25%635.00K

-50.13%560.00K

-87.79%479.00K

-84.51%454.00K

743.70%1.14M

-70.20%1.12M

233.11%3.92M

-16.73%2.93M

-92.39%135.00K

145.38%3.77M

-26.33%1.18M

113.85%3.52M

-74.75%1.77M

-10.90%1.54M

88.34%1.60M

-77.87%1.65M

362.91%7.03M

-47.17%1.72M

405.36%849.00K

3676.14%7.44M

682.47%1.52M

1417.67%3.26M

-34.38%168.00K

-62.90%197.00K

-44.25%194.00K

230.77%215.00K

-78.04%256.00K

617.57%531.00K

--348.00K

--65.00K

--1.17M

--74.00K

Return on equity

----

--13.00K

----

Special income (expenses)

71.34%1.12M

-1283.33%-71.00K

-80.20%97.00K

-91.63%118.00K

-81.18%656.00K

-90.16%6.00K

1300.00%490.00K

141100.00%1.41M

58200.00%3.49M

-64.53%61.00K

-92.54%35.00K

99.79%-1.00K

-128.57%-6.00K

105.64%172.00K

--469.00K

95.72%-480.00K

--21.00K

---3.05M

100.00%0.00

---11.21M

----

100.00%0.00

97.99%-4.60M

----

---1.00K

---228.51M

----

100.00%0.00

-100.00%0.00

----

98.56%-233.00K

-84.48%436.00K

-81.94%5.26M

279.58%20.23M

-4.41%-16.18M

790.17%2.81M

264809.09%29.14M

-15547.22%-11.27M

-25925.00%-15.49M

-3970.00%-407.00K

-26.67%11.00K

-105.29%-72.00K

-77.27%60.00K

---10.00K

107.08%15.00K

1037.93%1.36M

--264.00K

--0.00

---212.00K

---145.00K

- Gains from disposal of fixed assets

----

-100.00%0.00

100.00%0.00

----

--31.00K

---20.46M

---31.00K

----

Other non-operating income (expenses)

----

---27.00K

--27.00K

--20.00K

----

100.00%0.00

----

---12.91M

----

Income before tax

65.75%-776.00K

-27.45%-3.77M

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227.00K

69.02%-5.58M

-26.19%-6.88M

38.72%-2.98M

81.67%-5.44M

-20.69%-18.02M

-89.60%-5.45M

72.10%-4.86M

-1637.53%-29.68M

-915.85%-14.93M

90.37%-2.88M

-524.67%-17.42M

62.13%-1.71M

65.26%-1.47M

87.33%-29.88M

69.29%-2.79M

55.31%-4.51M

29.79%-4.23M

-80.50%-235.78M

-268.70%-9.08M

-99.51%-10.09M

-113.01%-6.03M

-3498.48%-130.63M

-259.62%-2.46M

-134.45%-5.06M

89.17%-2.83M

-114.54%-3.63M

-94.26%1.54M

171.57%14.68M

-39.98%-26.11M

59.90%-1.69M

10391.19%26.86M

-5444.86%-20.52M

-4996.99%-18.66M

-1055.89%-4.22M

17.14%-261.00K

-176.76%-370.00K

55.53%-366.00K

74.20%-365.00K

86.85%-315.00K

178.37%482.00K

---823.00K

---1.42M

---2.40M

---615.00K

Income tax

----

--0.00

----

--0.00

----

--0.00

Income after tax

65.75%-776.00K

-27.45%-3.77M

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227.00K

69.02%-5.58M

-26.19%-6.88M

38.72%-2.98M

81.67%-5.44M

-20.69%-18.02M

-89.60%-5.45M

72.10%-4.86M

-1637.53%-29.68M

-915.85%-14.93M

90.37%-2.88M

-524.67%-17.42M

62.13%-1.71M

65.26%-1.47M

87.33%-29.88M

69.29%-2.79M

55.31%-4.51M

29.79%-4.23M

-80.50%-235.78M

-268.70%-9.08M

-99.51%-10.09M

-113.01%-6.03M

-3498.48%-130.63M

-259.62%-2.46M

-134.45%-5.06M

89.17%-2.83M

-114.54%-3.63M

-94.26%1.54M

171.57%14.68M

-39.98%-26.11M

59.90%-1.69M

10391.19%26.86M

-5444.86%-20.52M

-4996.99%-18.66M

-1055.89%-4.22M

17.14%-261.00K

-176.76%-370.00K

55.53%-366.00K

74.20%-365.00K

86.85%-315.00K

178.37%482.00K

---823.00K

---1.42M

---2.40M

---615.00K

Net income from continuous operations

65.75%-776.00K

-27.45%-3.77M

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227.00K

69.02%-5.58M

-26.19%-6.88M

38.72%-2.98M

81.67%-5.44M

-20.69%-18.02M

-89.60%-5.45M

72.10%-4.86M

-1637.53%-29.68M

-915.85%-14.93M

90.37%-2.88M

-524.67%-17.42M

62.13%-1.71M

65.26%-1.47M

87.33%-29.88M

69.29%-2.79M

55.31%-4.51M

29.79%-4.23M

-80.50%-235.78M

-268.70%-9.08M

-99.51%-10.09M

-113.01%-6.03M

-3498.48%-130.63M

-259.62%-2.46M

-134.45%-5.06M

89.17%-2.83M

-114.54%-3.63M

-94.26%1.54M

171.57%14.68M

-39.98%-26.11M

59.90%-1.69M

10391.19%26.86M

-5444.86%-20.52M

-4996.99%-18.66M

-1055.89%-4.22M

17.14%-261.00K

-176.76%-370.00K

55.53%-366.00K

74.20%-365.00K

86.92%-315.00K

178.37%482.00K

---823.00K

---1.42M

---2.41M

---615.00K

Other net gains and losses

----

---13.00K

----

Net Income attributable to non-controlling interests

----

--0.00

----

--0.00

100.00%0.00

-100.00%0.00

-58.33%-19.00K

102.17%1.00K

111.11%1.00K

-92.86%1.00K

80.65%-12.00K

-206.67%-46.00K

30.77%-9.00K

--14.00K

---62.00K

---15.00K

---13.00K

----

Net income attributable to controlling interests

65.75%-776.00K

-27.45%-3.77M

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227.00K

69.02%-5.58M

-26.19%-6.88M

38.72%-2.98M

81.67%-5.44M

-20.69%-18.02M

-89.60%-5.45M

72.10%-4.86M

-1637.53%-29.68M

-915.85%-14.93M

90.37%-2.88M

-524.67%-17.42M

62.13%-1.71M

65.26%-1.47M

87.33%-29.88M

69.29%-2.79M

55.31%-4.51M

29.79%-4.23M

-80.50%-235.78M

-268.70%-9.08M

-99.51%-10.09M

-113.01%-6.03M

-3498.48%-130.63M

-259.62%-2.46M

-134.45%-5.06M

89.17%-2.83M

-114.54%-3.63M

-94.26%1.54M

171.57%14.68M

-40.12%-26.11M

59.91%-1.69M

10351.91%26.86M

-5429.92%-20.52M

-5164.41%-18.64M

-1222.88%-4.22M

14.38%-262.00K

-179.27%-371.00K

53.48%-354.00K

77.21%-319.00K

87.22%-306.00K

176.10%468.00K

---761.00K

---1.40M

---2.40M

---615.00K

Net income attributable to common shareholders

65.75%-776.00K

-27.45%-3.77M

-41.18%-3.41M

-86.24%-3.71M

-898.24%-2.27M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227.00K

69.02%-5.58M

-26.19%-6.88M

38.72%-2.98M

81.67%-5.44M

-20.69%-18.02M

-89.60%-5.45M

72.10%-4.86M

-1637.53%-29.68M

-915.85%-14.93M

90.37%-2.88M

-524.67%-17.42M

62.13%-1.71M

65.26%-1.47M

87.33%-29.88M

69.29%-2.79M

55.31%-4.51M

29.79%-4.23M

-80.50%-235.78M

-268.70%-9.08M

-99.51%-10.09M

-113.01%-6.03M

-3498.48%-130.63M

-259.62%-2.46M

-134.45%-5.06M

89.17%-2.83M

-114.54%-3.63M

-94.26%1.54M

171.57%14.68M

-40.12%-26.11M

59.91%-1.69M

10351.91%26.86M

-5429.92%-20.52M

-5164.41%-18.64M

-1222.88%-4.22M

14.38%-262.00K

-179.27%-371.00K

53.48%-354.00K

77.21%-319.00K

87.22%-306.00K

176.10%468.00K

---761.00K

---1.40M

---2.40M

---615.00K

Basic earnings per share

79.84%-0.33

22.02%-1.67

13.60%-1.53

-45.67%-2.17

-841.64%-1.64

58.65%-2.14

73.14%-1.77

48.00%-1.49

96.53%-0.17

66.63%-5.19

-26.19%-6.58

34.24%-2.86

90.84%-5.02

91.74%-15.54

72.73%-5.21

96.48%-4.35

-341.09%-54.82

-1611.48%-188.10

92.62%-19.11

-351.06%-123.58

72.39%-12.43

74.24%-10.99

89.19%-259.12

70.35%-27.40

56.16%-45.02

30.31%-42.67

42.32%-2.40K

96.48%-92.41

99.24%-102.68

99.58%-61.23

79.45%-4.16K

-125.92%-2.62K

-110.42%-13.45K

99.13%-14.55K

81.25%-20.22K

-99.41%10.12K

109.79%129.01K

-38.20%-1.66M

60.56%-107.86K

9845.65%1.71M

-5200.00%-1.32M

-4979.03%-1.20M

-1176.79%-273.49K

13.21%-17.59K

-175.58%-24.86K

61.25%-23.71K

84.09%-21.42K

92.71%-20.27K

139.63%32.90K

---61.20K

---134.64K

---278.08K

---83.00K

Diluted earnings per share

79.84%-0.33

22.02%-1.67

13.60%-1.53

-45.67%-2.17

-841.64%-1.64

58.65%-2.14

73.14%-1.77

48.00%-1.49

96.53%-0.17

66.63%-5.19

-26.19%-6.58

34.24%-2.86

90.84%-5.02

91.74%-15.54

72.73%-5.21

96.48%-4.35

-341.09%-54.82

-1611.48%-188.10

92.62%-19.11

-351.06%-123.58

72.39%-12.43

74.24%-10.99

89.19%-259.12

70.35%-27.40

56.16%-45.02

30.31%-42.67

42.32%-2.40K

96.48%-92.41

99.24%-102.68

99.58%-61.23

79.45%-4.16K

-128.22%-2.62K

-110.42%-13.45K

99.13%-14.55K

81.25%-20.22K

-98.89%9.29K

109.79%129.01K

-38.20%-1.66M

60.56%-107.86K

4858.70%837.29K

-5200.00%-1.32M

-4979.03%-1.20M

-1176.79%-273.49K

13.21%-17.59K

---24.86K

61.25%-23.71K

84.09%-21.42K

92.71%-20.27K

100.00%0.00

---61.20K

---134.64K

---278.08K

---83.00K

Dividend per share

--0.00

Currency unit

USD

Audit opinions

--

GT Biopharma Inc

1.780USD

GT Biopharma Inc

1.780

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement